{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:07:55Z","timestamp":1773284875164,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ijantimicag.2006.04.010","type":"journal-article","created":{"date-parts":[[2006,8,10]],"date-time":"2006-08-10T11:53:52Z","timestamp":1155210832000},"page":"238-243","source":"Crossref","is-referenced-by-count":23,"title":["In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia\u2013Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)"],"prefix":"10.1016","volume":"28","author":[{"given":"Po-Ren","family":"Hsueh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa A.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"DiNubile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilas","family":"Satischandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"McCarroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2006.04.010_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dki117","article-title":"In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"55","author":"Paterson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib2","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th ed. Approved Standard M7-A6. Villanova, PA: NCCLS; 2003."},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib3","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Thirteenth Informational Supplement. Supplemental Tables M100-S13. Villanova, PA: NCCLS; 2003."},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat Med"},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0163-4453(03)00096-3","article-title":"Extended-spectrum \u03b2-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control","volume":"47","author":"St\u00fcrenburg","year":"2003","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3201\/eid0702.010238","article-title":"Controversies about extended-spectrum and AmpC beta-lactamases","volume":"7","author":"Thompson","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jac\/dkg284","article-title":"AmpC \u03b2-lactamases: what do we need to know for the future?","volume":"52","author":"Hanson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib8","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1128\/JCM.43.9.4891-4894.2005","article-title":"Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia","volume":"43","author":"Song","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0732-8893(03)00041-5","article-title":"Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae producing extended-spectrum \u03b2-lactamases isolated in Japan","volume":"46","author":"Komatsu","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jac\/dkh274","article-title":"Evaluation of a new cefepime\u2013clavulanate ESBL Etest to detect extended-spectrum \u03b2-lactamases in an Enterobacteriaceae strain collection","volume":"54","author":"St\u00fcrenburg","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/JCM.42.1.269-275.2004","article-title":"Effects of inoculum and \u03b2-lactamase activity in AmpC- and extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology","volume":"42","author":"Queenan","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/jac\/dkh440","article-title":"Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum \u03b2-lactamases and strains with extended-spectrum activity of the chromosomal \u03b2-lactamase","volume":"54","author":"Decr\u00e9","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nrmicro1047","article-title":"Epidemiological interpretation of antibiotic resistance studies\u2014what are we missing?","volume":"2","author":"Schwaber","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2006.04.010_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nrmicro1049","article-title":"Antibiotic resistance: a view from the prescriber","volume":"2","author":"Finch","year":"2004","journal-title":"Nat Rev Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906002202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906002202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T11:25:33Z","timestamp":1547465133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857906002202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0924857906002202"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.04.010","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}